PSB-SB-487: Difference between revisions
Content deleted Content added
Citation bot (talk | contribs) Add: url. | Use this bot. Report bugs. | Suggested by Abductive | Category:Chemical articles without CAS registry number | via #UCB_Category 1289/1515 |
Vortioxetine (talk | contribs) m Added SVG of structure |
||
Line 1: | Line 1: | ||
{{Drugbox |
{{Drugbox |
||
| IUPAC_name = 7-(1,1-Dimethyloctyl)-5-hydroxy-3-(2-hydroxybenzyl)-2H-chromen-2-one |
| IUPAC_name = 7-(1,1-Dimethyloctyl)-5-hydroxy-3-(2-hydroxybenzyl)-2H-chromen-2-one |
||
| image = PSB-SB- |
| image = PSB-SB-487 Structure.svg |
||
| width = 300 |
| width = 300 |
||
<!--Clinical data--> |
<!--Clinical data--> |
Revision as of 00:09, 13 June 2021
File:PSB-SB-487 Structure.svg | |
Identifiers | |
---|---|
| |
PubChem CID | |
ChemSpider | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C26H32O4 |
Molar mass | 408.53 g·mol−1 |
3D model (JSmol) | |
| |
|
PSB-SB-487 is a coumarin derivative which is an antagonist at the former orphan receptor GPR55. Unlike older GPR55 antagonists such as O-1918, PSB-SB-487 has good selectivity over the related receptor GPR18, with an IC50 of 113nM at GPR55 vs 12500nM at GPR18.[1] However it has poorer selectivity over other related receptors, acting as a weak antagonist at CB1 with a Ki of 1170nM, and a partial agonist at CB2 with a Ki of 292nM.[2]
See also
References
- ^ Rempel V, Volz N, Gläser F, Nieger M, Bräse S, Müller CE (June 2013). "Antagonists for the orphan G-protein-coupled receptor GPR55 based on a coumarin scaffold". Journal of Medicinal Chemistry. 56 (11): 4798–810. doi:10.1021/jm4005175. PMID 23679955.
- ^ Rempel V, Volz N, Hinz S, Karcz T, Meliciani I, Nieger M, et al. (September 2012). "7-Alkyl-3-benzylcoumarins: a versatile scaffold for the development of potent and selective cannabinoid receptor agonists and antagonists". Journal of Medicinal Chemistry. 55 (18): 7967–77. doi:10.1021/jm3008213. PMID 22916707.